Actuate Therapeutics Announces Plans to Expand Clinical Pipeline, Advancing Elraglusib ...

Initiation of phase 1 portion of the trial planned in 2H 2026-Phase 2 portion of the trial will initiate development of the elraglusib tablet in ...